|

An Observational Study of Local Relapse After High Grade Osteosarcoma

RECRUITINGSponsored by Istituto Ortopedico Rizzoli
Actively Recruiting
SponsorIstituto Ortopedico Rizzoli
Started2022-06-13
Est. completion2026-06-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06017518

Summary

multicenter retrospective and prospective study in patients with high-grade osteosarcoma

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases
* Adequate patient compliance to follow-up visits
* Written informed consent prior to any study-specific analysis and/or data collection
* No age limits

Exclusion Criteria:

* Cases of LR demonstrated after \> 3 months after metastatic disease
* Impossibility to ensure adequate compliance

Conditions2

CancerOsteosarcoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.